Metadata
Author: patents-wipo
Data
English[en]
The amino acid moiety of the modified RARS protein of the present invention which binds to canavanine is effective for screening a material, that is, a cancer therapeutic agent, capable of acting as a competitive inhibitor of arginine, such as canavanine.
French[fr]
La fraction acide aminé de la protéine RARS modifiée de la présente invention qui se lie à la canavanine est efficace pour le criblage d'une substance, c'est-à-dire d'un agent thérapeutique du cancer, capable d'agir en tant qu'inhibiteur concurrent de l'arginine, tel que la canavanine.
Korean[ko]
본 발명의 카나바닌과 결합하는 변형 RARS 단백질의 아미노산 잔기를 이용하여 카나바닌처럼 아르기닌에 대한 경쟁적 저해제로 작용할 수 있는 물질, 즉 암치료제를 선별하는데 효과적이다.